Put Options

26 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $888,595 - $1.6 Million
-21,500 Reduced 47.36%
23,900 $1.01 Million
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $500,803 - $656,553
8,900 Added 24.38%
45,400 $3.14 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $2.16 Million - $2.76 Million
36,500 New
36,500 $2.7 Million
Q2 2023

Aug 23, 2023

BUY
$62.68 - $95.05 $570,388 - $864,955
9,100 Added 35.41%
34,800 $3.27 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $2.84 Million - $4.26 Million
-60,200 Reduced 70.08%
25,700 $1.7 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $2.11 Million - $3.69 Million
69,400 Added 420.61%
85,900 $4.25 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $527,505 - $814,605
16,500 New
16,500 $547,000
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $683,712 - $1.46 Million
-19,200 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $1.11 Million - $1.59 Million
-19,300 Reduced 50.13%
19,200 $1.37 Million
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $282,750 - $392,652
-3,900 Reduced 9.2%
38,500 $3 Million
Q3 2021

Nov 12, 2021

SELL
$90.24 - $124.05 $198,528 - $272,910
-2,200 Reduced 4.93%
42,400 $3.89 Million
Q2 2021

Aug 06, 2021

BUY
$93.66 - $139.27 $1.04 Million - $1.55 Million
11,100 Added 33.13%
44,600 $5.72 Million
Q1 2021

May 14, 2021

SELL
$116.57 - $155.01 $4.14 Million - $5.5 Million
-35,500 Reduced 51.45%
33,500 $4.14 Million
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $9,961 - $14,212
100 Added 0.15%
69,000 $9.34 Million
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $379,184 - $530,452
5,200 Added 8.16%
68,900 $7.03 Million
Q2 2020

Aug 13, 2020

SELL
$55.75 - $92.75 $1.66 Million - $2.76 Million
-29,800 Reduced 31.87%
63,700 $5.48 Million
Q1 2020

May 11, 2020

BUY
$37.9 - $104.44 $280,460 - $772,856
7,400 Added 8.59%
93,500 $5.46 Million
Q4 2019

Feb 12, 2020

BUY
$77.66 - $99.74 $2.36 Million - $3.03 Million
30,400 Added 54.58%
86,100 $7.91 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $63,259 - $85,743
700 Added 1.27%
55,700 $5.12 Million
Q2 2019

Aug 20, 2019

SELL
$89.51 - $118.04 $8,951 - $11,804
-100 Reduced 0.18%
55,000 $6.49 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $1.37 Million - $2.13 Million
-22,100 Reduced 28.63%
55,100 $4.77 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $1.59 Million - $2.35 Million
-28,400 Reduced 26.89%
77,200 $4.72 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $507,045 - $846,299
10,500 Added 11.04%
105,600 $8.33 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $430,056 - $621,324
-10,800 Reduced 10.2%
95,100 $3.84 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $60,437 - $78,663
-1,300 Reduced 1.21%
105,900 $5.56 Million
Q3 2017

Nov 15, 2017

BUY
$37.05 - $47.12 $3.97 Million - $5.05 Million
107,200
107,200 $5.05 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.